PLSE Q1 2022 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

Q1 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$444,000

Gross Profit

-$465,000-104.7% margin

Operating Income

-$17M-3890.3% margin

Net Income

-$17M-3890.3% margin

EPS (Diluted)

$-0.58

QoQ Revenue Growth

-47.4%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$40M

Total Liabilities

$19M

Stockholders' Equity

$21M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$444,000	$0	—
Gross Profit	-$465,000	$0	—
Operating Income	-$17M	-$19M	+6.8%
Net Income	-$17M	-$19M	+7.3%